메뉴 건너뛰기




Volumn 41, Issue 6, 2014, Pages 694-696

Good is not Good Enough: The Benchmark Stroke Door-to-Needle Time Should be 30 Minutes

(35)  Kamal, Noreen a   Benavente, Oscar g   Boyle, Karl i   Buck, Brian d   Butcher, Ken d,i   Casaubon, Leanne K l,m   Côté, Robert t   Demchuk, Andrew M a   Deschaintre, Yan i   Dowlatshahi, Dar o   Gubitz, Gordon J v   Hunter, Gary h   Jeerakathil, Tom d   Jin, Albert i   Lang, Eddy a,b   Lanthier, Sylvain u   Lindsay, Patrice q   Newcommon, Nancy c   Mandzia, Jennifer r   Norris, Colleen M e,f   more..


Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; HEART INFARCTION; HUMAN; INJURY; NOTE; PATIENT CARE; PRIORITY JOURNAL; TIME TO TREATMENT; TOTAL QUALITY MANAGEMENT; CANADA; FIBRINOLYTIC THERAPY; NEEDLE; PROCEDURES; QUALITY CONTROL; STANDARDS; STROKE;

EID: 84938199130     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/cjn.2014.41     Document Type: Note
Times cited : (39)

References (25)
  • 2
    • 33644874026 scopus 로고    scopus 로고
    • Time is brain-quantified
    • Saver JL. Time is brain-quantified. Stroke. 2006;37(1):263-6.
    • (2006) Stroke , vol.37 , Issue.1 , pp. 263-266
    • Saver, J.L.1
  • 3
    • 52649165720 scopus 로고    scopus 로고
    • Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
    • Hacke W, Kaste M, Bluhmki E, Brozman M, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. NEJM. 2008;359(13):1317-29.
    • (2008) NEJM , vol.359 , Issue.13 , pp. 1317-1329
    • Hacke, W.1    Kaste, M.2    Bluhmki, E.3    Brozman, M.4
  • 4
    • 71849095831 scopus 로고    scopus 로고
    • Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): Additional outcomes and subgroup analysis of a randomised controlled trial
    • Bluhmki E, Chamorro A, Dávalos A, et al. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol. 2009;8(12):1095-102.
    • (2009) Lancet Neurol , vol.8 , Issue.12 , pp. 1095-1102
    • Bluhmki, E.1    Chamorro, A.2    Dávalos, A.3
  • 5
    • 84862625338 scopus 로고    scopus 로고
    • The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): A randomised controlled trial
    • Sandercock P, Wardlaw JM, Lindley RI, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet. 2012;379(9834):2352-63.
    • (2012) Lancet , vol.379 , Issue.9834 , pp. 2352-2363
    • Sandercock, P.1    Wardlaw, J.M.2    Lindley, R.I.3
  • 6
    • 80052403906 scopus 로고    scopus 로고
    • Revised and updated recommendations for the establishment of primary stroke centers: A summary statement from the brain attack coalition
    • Alberts MJ, Latchaw RE, Jagoda A, et al. Revised and updated recommendations for the establishment of primary stroke centers: A summary statement from the brain attack coalition. Stroke. 2011;42:2651-65.
    • (2011) Stroke , vol.42 , pp. 2651-2665
    • Alberts, M.J.1    Latchaw, R.E.2    Jagoda, A.3
  • 9
    • 84944115903 scopus 로고    scopus 로고
    • American Stroke Association
    • American Stroke Association. Target: Stroke Time Lost is Brain Lost. http://www.strokeassociation.org/idc/groups/heart-public/@wcm/@hcm/@gwtg/documents/downloadable/ucm-308277. pdf.
    • Target: Stroke Time Lost Is Brain Lost
  • 10
    • 84944115904 scopus 로고    scopus 로고
    • On behalf of the acute stroke care writing group. Chapter 3: Hyperacute stroke care
    • In Lindsay MP, Gubitz G, Bayley M, Phillips S (Editors) Ottawa, Ontario Canada:Canadian Stroke Network and Heart and Stroke Foundation of Canada
    • Casaubon LK, Suddes M, on behalf of the Acute Stroke Care Writing Group. Chapter 3: Hyperacute Stroke Care. In Lindsay MP, Gubitz G, Bayley M, Phillips S (Editors) on behalf of the Canadian Stroke Best Practices and Standards Advisory Committee Canadian Best Practice Recommendations for Stroke Care. 2013. Ottawa, Ontario Canada:Canadian Stroke Network and Heart and Stroke Foundation of Canada.
    • (2013) On Behalf of the Canadian Stroke Best Practices and Standards Advisory Committee Canadian Best Practice Recommendations for Stroke Care
    • Casaubon, L.K.1    Suddes, M.2
  • 12
    • 0033864825 scopus 로고    scopus 로고
    • Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke
    • Christou I, Alexandrov AV, Burgin WS, et al. Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke. Stroke. 2000;3:1812-6.
    • (2000) Stroke , vol.3 , pp. 1812-1816
    • Christou, I.1    Alexandrov, A.V.2    Burgin, W.S.3
  • 13
    • 84879069684 scopus 로고    scopus 로고
    • Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke
    • Saver JL, Fonarow GC, Smith EE, et al. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA. 2013;309(23):2480-8.
    • (2013) JAMA , vol.309 , Issue.23 , pp. 2480-2488
    • Saver, J.L.1    Fonarow, G.C.2    Smith, E.E.3
  • 14
    • 0030054086 scopus 로고    scopus 로고
    • Magnitude of benefit from earlier thrombolytic treatment in acute myocardial infarction: New evidence fromGrampian region early anistreplase trial (GREAT)
    • Rawles J.. Magnitude of benefit from earlier thrombolytic treatment in acute myocardial infarction: new evidence fromGrampian region early anistreplase trial (GREAT). BMJ. 1996;312(7025):212-5.
    • (1996) BMJ , vol.312 , Issue.7025 , pp. 212-215
    • Rawles, J.1
  • 15
    • 0034931505 scopus 로고    scopus 로고
    • The golden hour: Scientific fact or medical urban legend
    • Lerner EB, Moscati RM. The golden hour: scientific fact or medical "urban legend"? Acad Emerg Med. 2001;8(7):758-60.
    • (2001) Acad Emerg Med , vol.8 , Issue.7 , pp. 758-760
    • Lerner, E.B.1    Moscati, R.M.2
  • 16
    • 77952112006 scopus 로고    scopus 로고
    • Time to treatment with intravenous alteplase and outcome in stroke: An updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials
    • Lees KR, Bluhmki E, Von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375(9729):1695-703.
    • (2010) Lancet , vol.375 , Issue.9729 , pp. 1695-1703
    • Lees, K.R.1    Bluhmki, E.2    Von Kummer, R.3
  • 17
    • 33747057446 scopus 로고    scopus 로고
    • Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment
    • Lindsberg PJ, Häppölä O, Kallela M, Valanne L, KuismaM, Kaste M. Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment. Neurology. 2006;67(2):334-6.
    • (2006) Neurology , vol.67 , Issue.2 , pp. 334-336
    • Lindsberg, P.J.1    Häppölä, O.2    Kallela, M.3    Valanne, L.4    Kuismam Kaste, M.5
  • 19
    • 84884526342 scopus 로고    scopus 로고
    • Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months
    • Meretoja A, Weir L, Ugalde M, et al. Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months. Neurology. 2013;81(12):1071-6.
    • (2013) Neurology , vol.81 , Issue.12 , pp. 1071-1076
    • Meretoja, A.1    Weir, L.2    Ugalde, M.3
  • 20
    • 80053298469 scopus 로고    scopus 로고
    • Improving door-to-needle times in acute ischemic stroke: The design and rationale for the American Heart Association/American stroke association's target: Stroke initiative
    • Fonarow GC, Smith EE, Saver JL, et al. Improving door-to-needle times in acute ischemic stroke: The design and rationale for the american heart association/american stroke association's target: Stroke initiative. Stroke. 2011;42:2983-9.
    • (2011) Stroke , vol.42 , pp. 2983-2989
    • Fonarow, G.C.1    Smith, E.E.2    Saver, J.L.3
  • 21
    • 84898811265 scopus 로고    scopus 로고
    • Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after initiation of a quality improvement initiative
    • Fonarow GC, Zhao X, Smith EE, et al. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after initiation of a quality improvement initiative. JAMA. 2014;311(16):1632-40.
    • (2014) JAMA , vol.311 , Issue.16 , pp. 1632-1640
    • Fonarow, G.C.1    Zhao, X.2    Smith, E.E.3
  • 22
    • 80053298469 scopus 로고    scopus 로고
    • Improving door-to-needle times in acute ischemic stroke the design and rationale for the American Heart Association/American Stroke Association's target: Stroke initiative
    • Fonarow GC, Smith EE, Saver JL, et al. Improving door-to-needle times in acute ischemic stroke the design and rationale for the American Heart Association/American Stroke Association's target: stroke initiative. Stroke. 2011;42(10):2983-9.
    • (2011) Stroke , vol.42 , Issue.10 , pp. 2983-2989
    • Fonarow, G.C.1    Smith, E.E.2    Saver, J.L.3
  • 23
    • 84863663502 scopus 로고    scopus 로고
    • Canadian Stroke Network
    • Canadian Stroke Network. The Quality of Stroke Care in Canada. 2011. http://www.canadianstrokenetwork.ca/wp-content/uploads/2011/06/QoSC-EN1.pdf.
    • (2011) The Quality of Stroke Care in Canada
  • 25
    • 67650079313 scopus 로고    scopus 로고
    • A review of the evidence for the use of telemedicine within stroke systems of care. A scientific statement from the American Heart Association/American Stroke Association
    • Schwamm LH, Holloway RG, Amarenco P, et al. A review of the evidence for the use of telemedicine within stroke systems of care. A scientific statement from the American Heart Association/American Stroke Association. Stroke. 2009;40:2616-34.
    • (2009) Stroke , vol.40 , pp. 2616-2634
    • Schwamm, L.H.1    Holloway, R.G.2    Amarenco, P.3    Al, E.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.